Personal information

Activities

Employment (3)

Jotbody (HK) Limited: Homng Komng SAR, HK

2021-07 to present | Senior scientist and head of innovative product development
Employment
Source: Self-asserted source
Marco Pirisinu

City University of Hong Kong: Hong Kong, HK

2019-05-14 to present | Research fellow (Biomedical Science)
Employment
Source: Self-asserted source
Marco Pirisinu

China-US (Henan) Hormel Cancer Institute: Zhengzhou, CN

2016-01-05 to 2019-12-16 | Postdoctoral fellow
Employment
Source: Self-asserted source
Marco Pirisinu

Education and qualifications (6)

Karolinska Institutet: Stockholm, SE

2015 to 2016 | Associate Researcher (Toxicology )
Education
Source: Self-asserted source
Marco Pirisinu

Stockholms Universitet: Stockholm, SE

2013 to 2014 | PhD internship (Neurochemistry and toxicology)
Qualification
Source: Self-asserted source
Marco Pirisinu

University of Sassari: Sassari, Sardegna, IT

2011 to 2014 | PhD in Neuroscience (Biomedical Science/ Pharmacology)
Education
Source: Self-asserted source
Marco Pirisinu

Ospedale Civile Paolo Dettori: Tempio Pausania, Sardinia, IT

2010 to 2011 | Internship (Biochemical and microbiological analysis)
Qualification
Source: Self-asserted source
Marco Pirisinu

University of Sassari: Sassari, Sardegna, IT

2007 to 2009 | MSc in applied and molecular biology
Education
Source: Self-asserted source
Marco Pirisinu

University of Sassari: Sassari, Sardegna, IT

2002 to 2006 | B.S. in biological science
Education
Source: Self-asserted source
Marco Pirisinu

Professional activities (1)

American Association For The Advancement of Science: Washington D.C., District of Columbia, US

Membership
Source: Self-asserted source
Marco Pirisinu

Funding (1)

Hong Kong seed 300

Award
City University of Hong Kong (Hong Kong, CN)
Source: Self-asserted source
Marco Pirisinu

Works (14)

The Long Journey of Extracellular Vesicles towards Global Scientific Acclamation

Advanced Pharmaceutical Bulletin
2023-07-10 | Journal article
Contributors: Marco Pirisinu
Source: check_circle
Crossref

Surface-engineered extracellular vesicles for targeted delivery of therapeutic RNAs and peptides for cancer therapy

Theranostics
2022 | Journal article
Part of ISSN: 1838-7640
Source: Self-asserted source
Marco Pirisinu

CD33-targeting extracellular vesicles deliver antisense oligonucleotides against FLT3-ITD and miR-125b for specific treatment of acute myeloid leukaemia.

Cell proliferation
2022-07-18 | Journal article
Contributors: Huan CHEN; Jayasinghe MK; Yeo EYM; Wu Z; Marco Pirisinu; Pirisinu M; Usman WM; Pham TT; Lim KW; Tran NV et al.
Source: Self-asserted source
Marco Pirisinu

The Role of in silico Research in Developing Nanoparticle-Based Therapeutics

Frontiers in Digital Health
2022-03-16 | Journal article
Part of ISSN: 2673-253X
Source: Self-asserted source
Marco Pirisinu

Harnessing Extracellular Vesicles from Red Blood Cells for Targeted Delivery of Therapeutic Peptides and RNAs for Leukemia Treatment

Blood
2021-11-05 | Journal article
Part of ISSN: 0006-4971
Part of ISSN: 1528-0020
Source: Self-asserted source
Marco Pirisinu

ISEV2021 Abstract Book

Journal of Extracellular Vesicles
2021-05 | Journal article
Part of ISSN: 2001-3078
Part of ISSN: 2001-3078
Source: Self-asserted source
Marco Pirisinu

New approaches in extracellular vesicle engineering for improving the efficacy of anti-cancer therapies.

Seminars in cancer biology
2021-02-17 | Journal article
Source: Self-asserted source
Marco Pirisinu

Covalent conjugation of extracellular vesicles with peptides and nanobodies for targeted therapeutic delivery.

Journal of extracellular vesicles
2021-02-16 | Journal article
Source: Self-asserted source
Marco Pirisinu

Extracellular Vesicles as an Efficient and Versatile System for Drug Delivery.

Cells
2020-09-29 | Journal article
Source: Self-asserted source
Marco Pirisinu

Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation.

Seminars in cancer biology
2020-09-22 | Journal article
Source: Self-asserted source
Marco Pirisinu

Analysis of hydrophobic and hydrophilic moments of short penetrating peptides for enhancing mitochondrial localization: prediction and validation.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2019-03-27 | Journal article
Source: Self-asserted source
Marco Pirisinu

3D profilometric characterization of the aged skin surface using a skin replica and alicona Mex software.

Scanning
2015-08-10 | Journal article
Source: Self-asserted source
Marco Pirisinu

Novel cell-penetrating peptide targeting mitochondria.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2015-07-20 | Journal article
Source: Self-asserted source
Marco Pirisinu

Further in-vitro characterization of an implantable biosensor for ethanol monitoring in the brain.

Sensors (Basel, Switzerland)
2013-07-23 | Journal article
Source: Self-asserted source
Marco Pirisinu